Novo Nordisk expects 27% sales surge this year but faces price pressure amid Eli Lilly competition ...Middle East

Fortune - News
Novo Nordisk expects 27% sales surge this year but faces price pressure amid Eli Lilly competition
The market for obesity treatments may soar above $80 billion by 2030 according to analysts.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk expects 27% sales surge this year but faces price pressure amid Eli Lilly competition )

Apple Storegoogle play

Also on site :